Skip to main content
William Gray, MD, Cardiology, Wynnewood, PA, Bryn Mawr Hospital

WilliamAnthonyGrayMD, FACC, FSCAI

Cardiology Wynnewood, PA

Interventional Cardiology

System Chief, Cardiovascular Diseases | Co-Director, Lankenau Heart Institute | Main Line Health | Philadelphia, PA

Dr. Gray is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Gray's full profile

Already have an account?

  • Office

    100 E Lancaster Ave
    MOB East, Suite 356
    Wynnewood, PA 19096
    Phone+1 484-476-2639
    Fax+1 484-476-9000
  • Is this information wrong?

Summary

  • William A. Gray, MD, serves as System Chief, Division of Cardiovascular Diseases at Main Line Health and Co-Director of Lankenau Heart Institute in Philadelphia, PA.

    Dr. Gray’s clinical expertise includes the full range of catheter-based coronary, structural, and vascular diagnostic and therapeutic interventions, including repair of structural heart defects, mitral valve repair, left atrial appendage closure, aneurysm management, and head-to-toe arterial and venous interventions.

    Dr. Gray has served in cardiovascular leadership roles for nearly 20 years. Prior to joining Main Line Health, he served as Director of Endovascular Services at New York-Presbyterian/Columbia University Medical Center and as Director of Endovascular Services at Swedish Medical Center in Seattle.

    In addition to his leadership positions, Dr. Gray has been instrumental in growing the field of endovascular medicine through clinical training program development and oversight.

    Dr. Gray has significant research experience and has served as principal investigator for more than 50 clinical trials of coronary, endovascular, and structural heart interventions. He often is called upon to consult on development of both device and protocol design for national multicenter clinical trials of experimental devices, which has led to his increasing role as national principal investigator.

    Dr. Gray is a Fellow of the American College of Cardiology and a Fellow of The Society for Cardiac Angiography and Interventions. He has served on the editorial board of JACC: Cardiovascular Interventions and is a current editorial board member of Catheterization and Cardiovascular Interventions as well as a reviewer for several other peer-reviewed cardiovascular publications.

Education & Training

  • Brown University
    Brown UniversityFellowship, Cardiovascular Disease, 1988 - 1992
  • Brown University
    Brown UniversityResidency, Internal Medicine, 1984 - 1988
  • Lewis Katz School of Medicine at Temple University
    Lewis Katz School of Medicine at Temple UniversityClass of 1984

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2016 - 2024
  • NY State Medical License
    NY State Medical License 2005 - 2017
  • CT State Medical License
    CT State Medical License 2007 - 2008
  • WA State Medical License
    WA State Medical License 1999 - 2006
  • NM State Medical License
    NM State Medical License 1992 - 2002
  • RI State Medical License
    RI State Medical License 1986 - 1993
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Impact of Reducing Door to Balloon Times on Clinical Outcomes in STEMI 
    New York, NY - 2/12/2014

Press Mentions

  • Intact Vascular Announces Presentation of TOBA II Pivotal Data
    Intact Vascular Announces Presentation of TOBA II Pivotal DataOctober 8th, 2018
  • Boston Scientific Receives FDA Approval for Eluvia Drug-Eluting Vascular Stent
    Boston Scientific Receives FDA Approval for Eluvia Drug-Eluting Vascular StentOctober 1st, 2018
  • Boston Scientific’s Eluvia Peripheral Long Term Drug Eluting Stent FDA Approved
    Boston Scientific’s Eluvia Peripheral Long Term Drug Eluting Stent FDA ApprovedSeptember 27th, 2018
  • Join now to see all

Professional Memberships

Hospital Affiliations